Home › Calculator › ABVC Dividend Calculator 2026
ABVC Dividend DRIP Calculator 2026
117.65% YieldHealthcareABVC BioPharma, Inc. · NASDAQ
Price: $1.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ABVC pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ABVC snowball 📈
$10,000 in ABVC → $3788790338953.48M in 10 years · $315,470,662,949,729,340.00/month
About ABVC BioPharma, Inc. (ABVC) — Dividend Analysis 2026
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Compare ABVC with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ABVC DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ABVC position with:
🌍 ABVC Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ABVC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 100.00% | 97.20% | $10,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 94.12% | 91.32% | $9,412 / yr |
| 🇬🇧 UK ISA | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇬🇧 UK Taxable | 8.75% | 107.36% | 104.56% | $10,736 / yr |
| 🇨🇦 TFSA | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇨🇦 CA Taxable | 25% | 88.24% | 85.44% | $8,824 / yr |
| 🇦🇺 Super (pension) | 15% | 100.00% | 97.20% | $10,000 / yr |
| 🇦🇺 AU Taxable | 30% | 82.36% | 79.56% | $8,236 / yr |
| 🇩🇪 DE Taxable | 26.375% | 86.62% | 83.82% | $8,662 / yr |
| 🇫🇷 FR Taxable | 30% | 82.36% | 79.56% | $8,236 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ABVC Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ABVC Dividend Payment Schedule
ABVC pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ABVC vs Healthcare Benchmarks
How ABVC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ABVC sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ABVC Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2012-01-27 | 6,250 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ABVC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ABVC BioPharma, Inc. (ABVC) is currently trading at $1.70, 97% below its 52-week high. The current dividend yield is 117.65% based on an annual payout of $2.00 per share.
ABVC (ABVC BioPharma, Inc.) — 117.65% Dividend Yield Analysis
ABVC BioPharma, Inc. (ABVC) is a healthcare stock currently trading at $1.70 with a dividend yield of 117.65%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (117.65%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.